by University of Cambridge Graphical abstract. Credit: Journal of Clinical Investigation (2023). DOI: 10.1172/JCI162129 A cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including gout, heart failure, cardiomyopathy, and atrial fibrillation, say scientists at the University of Cambridge. In a study,...
